Sofgen Pharma S.A. (PRCWF, PROCF)
CIK 1863362 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Sofgen Pharma S.A..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Mar 30, 2026 | 3 | 0001213900-26-035984 |
| Mar 30, 2026 | 3 | 0001213900-26-036379 |
| Mar 30, 2026 | 3 | 0001213900-26-035988 |
| Mar 30, 2026 | 3 | 0001213900-26-036261 |
| Mar 30, 2026 | 3 | 0001213900-26-035986 |
| Mar 26, 2026 | 3 | 0001213900-26-034772 |
| Mar 26, 2026 | 3 | 0001213900-26-034776 |
| Mar 19, 2026 | 3 | 0001213900-26-031547 |
| Mar 18, 2026 | 3 | 0001213900-26-030584 |
| Mar 18, 2026 | 3 | 0001213900-26-030582 |
| Mar 16, 2026 | 15-12G | 0001213900-26-028339 |
| Mar 16, 2026 | 20-F | 0001213900-26-028293 |
| Dec 5, 2025 | 6-K | 0001213900-25-118714 |
| Nov 19, 2025 | 6-K | 0001213900-25-112342 |
| Sep 3, 2025 | 20-F | 0001628280-25-041512 |
| Aug 1, 2025 | 6-K | 0001213900-25-070719 |
| Jul 21, 2025 | 25-NSE | 0001354457-25-000715 |
| Jul 14, 2025 | 6-K | 0001213900-25-063804 |
| May 13, 2025 | 6-K | 0001213900-25-042301 |
| May 1, 2025 | NT 20-F | 0001213900-25-038561 |
| Apr 28, 2025 | SCHEDULE 13D | 0001104659-25-040275 |
| Apr 25, 2025 | SCHEDULE 13D | 0001104659-25-039600 |
| Apr 22, 2025 | SCHEDULE 13D | 0001213900-25-034049 |
| Apr 22, 2025 | SCHEDULE 13D | 0001213900-25-034047 |
| Apr 16, 2025 | SCHEDULE 13D/A | 0001213900-25-032715 |